tradingkey.logo
搜索

Procept Biorobotics Corp

PRCT
添加自选
21.780USD
-1.690-7.20%
交易中 美东报价延迟15分钟
1.22B总市值
亏损市盈率 TTM

关于 Procept Biorobotics Corp 公司

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Procept Biorobotics Corp简介

公司代码PRCT
公司名称Procept Biorobotics Corp
上市日期Sep 15, 2021
CEOWood (Larry L)
员工数量756
证券类型Ordinary Share
年结日Sep 15
公司地址150 Baytech Drive
城市SAN JOSE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编95134
电话16502329832
网址https://www.procept-biorobotics.com/
公司代码PRCT
上市日期Sep 15, 2021
CEOWood (Larry L)

Procept Biorobotics Corp公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
4.10K
+80.83%
Mr. Larry L. Wood
Mr. Larry L. Wood
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.20K
-9770.22%
Ms. Amy M. Dodrill
Ms. Amy M. Dodrill
Independent Director
Independent Director
--
--
Mr. Antal Desai
Mr. Antal Desai
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
79.32K
-0.45%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
16.16K
+20.51%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--

常见问题

Procept Biorobotics Corp的前五大股东是谁?

Procept Biorobotics Corp 的前五大股东如下:Dr. Frederic H. (Fred) Moll, M.D.

有多少机构持有Procept Biorobotics Corp(PRCT)的股份?

截至2026Q1,共有597家机构持有Procept Biorobotics Corp的股份,合计持有的股份价值约为65.01M,占公司总股份的114.22%。与2025Q4相比,机构持股有所增加,增幅为-1014187.00。

哪个业务部门对Procept Biorobotics Corp的收入贡献最大?

在2026Q1,Hand pieces and other consumables业务部门对Procept Biorobotics Corp的收入贡献最大,创收181.45M,占总收入的58.90%。